Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amphastar Pharma (NQ: AMPH ) 46.50 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 46.50 Bid (Size) 44.00 (2) Ask (Size) 54.67 (1) Prev. Close 46.50 Today's Range 46.50 - 46.50 52wk Range 36.56 - 65.92 Shares Outstanding 48,675,822 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability September 06, 2024 JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris. Via Benzinga Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference August 28, 2024 Via ACCESSWIRE Performance YTD -25.35% -25.35% 1 Month -1.02% -1.02% 3 Month +20.59% +20.59% 6 Month +10.87% +10.87% 1 Year +3.63% +3.63% More News Read More AMPH Stock Earnings: Amphastar Pharma Beats EPS, Beats Revenue for Q2 2024 August 07, 2024 Via InvestorPlace Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024 August 07, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024 July 31, 2024 Via ACCESSWIRE Why the growth investor may take a look at NASDAQ:AMPH. June 05, 2024 Via Chartmill Exploring NASDAQ:AMPH's growth characteristics. May 15, 2024 Via Chartmill Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 May 08, 2024 Via ACCESSWIRE NASDAQ:AMPH, an undervalued stock with good fundamentals. March 12, 2024 Via Chartmill 7 Biotech Stocks to Buy on the Dip: June 2024 June 24, 2024 Via InvestorPlace Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts June 18, 2024 Via MarketBeat Topics ETFs Economy Exposures Interest Rates Amphastar Announces Additional $50 Million Increase to its Share Buyback Program June 04, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference June 03, 2024 Via ACCESSWIRE Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol May 22, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023 February 28, 2024 Via ACCESSWIRE Delving into NASDAQ:AMPH's Growth Prospects. February 28, 2024 Via Chartmill Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade May 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference May 09, 2024 Via ACCESSWIRE AMPH Stock Earnings: Amphastar Pharma Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca May 01, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024 April 30, 2024 Via ACCESSWIRE Earnings Outlook For Amphastar Pharma February 27, 2024 Via Benzinga Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies April 10, 2024 Via Benzinga Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference April 01, 2024 Via ACCESSWIRE Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference March 06, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
